METHYLPHENIDATE HYDROCHLORIDE

METHYLPHENIDATE HYDROCHLORIDE was reported 58050 times

METHYLPHENIDATE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RESPIRATORY TRACT MALFORMATION 37 0.2782
1 PULMONARY MALFORMATION 67 0.1909
2 OPPOSITIONAL DEFIANT DISORDER 50 0.1266
3 CATAPLEXY 175 0.1235
4 DECREASED EYE CONTACT 35 0.1151
5 CHOREOATHETOSIS 77 0.1134
6 EDUCATIONAL PROBLEM 182 0.1094
7 LUNG CYST 41 0.1043
8 TRICHOTILLOMANIA 56 0.0956
9 PRECOCIOUS PUBERTY 52 0.0911
10 TIC 485 0.0888
11 PRODUCT INEFFECTIVE 66 0.0840
12 GROWTH RETARDATION 233 0.0791
13 SELF-DESTRUCTIVE BEHAVIOUR 64 0.0734
14 SOCIAL ANXIETY DISORDER 46 0.0700
15 DERMATILLOMANIA 41 0.0688
16 PRE-EXISTING CONDITION IMPROVED 428 0.0685
17 PARASOMNIA 48 0.0668
18 NARCOLEPSY 117 0.0619
19 SLEEP-RELATED EATING DISORDER 57 0.0608
20 HALLUCINATION, TACTILE 38 0.0571
21 OROMANDIBULAR DYSTONIA 41 0.0562
22 ATTENTION DEFICIT HYPERACTIVITY DISORDER 233 0.0553
23 DISTRACTIBILITY 63 0.0546
24 IMPULSIVE BEHAVIOUR 204 0.0543
25 ENURESIS 186 0.0460
26 CORONARY ARTERY DISSECTION 39 0.0454
27 TERMINAL INSOMNIA 80 0.0451
28 DISTURBANCE IN SOCIAL BEHAVIOUR 103 0.0437
29 DRUG SCREEN NEGATIVE 76 0.0432
30 PRODUCT ADMINISTRATION INTERRUPTED 310 0.0395
31 ABNORMAL SLEEP-RELATED EVENT 49 0.0371
32 SLEEP PARALYSIS 54 0.0368
33 HYPERKINESIA 77 0.0363
34 STEREOTYPY 34 0.0361
35 PSYCHOMOTOR HYPERACTIVITY 598 0.0360
36 LOGORRHOEA 126 0.0357
37 SOMNAMBULISM 220 0.0335
38 SUBSTANCE USE 49 0.0314
39 SLEEP APNOEA SYNDROME 587 0.0307
40 AGGRESSION 1486 0.0297
41 OBSESSIVE THOUGHTS 53 0.0294
42 SNORING 110 0.0291
43 ABNORMAL BEHAVIOUR 1131 0.0285
44 EXCESSIVE EYE BLINKING 42 0.0284
45 OBSTRUCTIVE SLEEP APNOEA SYNDROME 40 0.0274
46 HOMICIDAL IDEATION 111 0.0274
47 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 54 0.0273
48 DRUG TOLERANCE 136 0.0269
49 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 60 0.0268
50 SLEEP TALKING 45 0.0265
51 DISTURBANCE IN ATTENTION 1409 0.0261
52 IMPULSE-CONTROL DISORDER 53 0.0257
53 MUSCLE CONTRACTURE 51 0.0251
54 SUICIDAL BEHAVIOUR 104 0.0250
55 TRISMUS 129 0.0250
56 PRIAPISM 85 0.0246
57 OBSESSIVE-COMPULSIVE DISORDER 197 0.0245
58 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 33 0.0244
59 BRUXISM 131 0.0243
60 CHOREA 41 0.0238
61 DRUG DIVERSION 145 0.0235
62 KOUNIS SYNDROME 51 0.0224
63 SUBSTANCE USE DISORDER 70 0.0220
64 SOCIAL AVOIDANT BEHAVIOUR 126 0.0218
65 PRODUCT AVAILABILITY ISSUE 493 0.0216
66 SELF INJURIOUS BEHAVIOUR 65 0.0213
67 INTENTIONAL SELF-INJURY 418 0.0207
68 HANGOVER 72 0.0205
69 BIPOLAR DISORDER 222 0.0204
70 TORTICOLLIS 43 0.0203
71 GASTRIC BYPASS 44 0.0202
72 AFFECT LABILITY 194 0.0201
73 AUTISM SPECTRUM DISORDER 110 0.0200
74 INITIAL INSOMNIA 204 0.0199
75 PRE-ECLAMPSIA 94 0.0198
76 BEHAVIOUR DISORDER 107 0.0198
77 OCULOGYRIC CRISIS 42 0.0196
78 ANGER 659 0.0195
79 MATERNAL EXPOSURE DURING BREAST FEEDING 79 0.0195
80 PRODUCT SUBSTITUTION ISSUE 1121 0.0195
81 TACHYPHRENIA 67 0.0193
82 MAJOR DEPRESSION 139 0.0190
83 HALLUCINATION, AUDITORY 302 0.0190
84 PARANOIA 327 0.0189
85 SUBSTANCE ABUSE 153 0.0188
86 UNDERWEIGHT 37 0.0187
87 LIBIDO INCREASED 38 0.0187
88 SCREAMING 119 0.0187
89 HYPERPHAGIA 74 0.0185
90 PSYCHOTIC SYMPTOM 38 0.0184
91 PSYCHOTIC DISORDER 543 0.0184
92 SUICIDAL IDEATION 1683 0.0184
93 MYDRIASIS 234 0.0182
94 SELF-INJURIOUS IDEATION 76 0.0181
95 COMPULSIVE SHOPPING 37 0.0180
96 STARING 43 0.0178
97 FLAT AFFECT 41 0.0177
98 HYPERSEXUALITY 32 0.0175
99 DYSTONIA 338 0.0174
100 IRRITABILITY 1044 0.0173
101 PERSECUTORY DELUSION 43 0.0172
102 THERAPEUTIC RESPONSE CHANGED 109 0.0172
103 MANIA 280 0.0170
104 THERAPEUTIC PRODUCT EFFECT VARIABLE 66 0.0170
105 AGITATION 1245 0.0169
106 AFFECTIVE DISORDER 133 0.0169
107 HALLUCINATIONS, MIXED 71 0.0169
108 NEGATIVE THOUGHTS 49 0.0167
109 EXPOSURE VIA BREAST MILK 65 0.0163
110 HYPOMANIA 60 0.0163
111 APATHY 235 0.0161
112 BIPOLAR I DISORDER 35 0.0159
113 GAMBLING DISORDER 43 0.0159
114 PHYSICAL ASSAULT 33 0.0158
115 DISSOCIATION 121 0.0158
116 POST-TRAUMATIC STRESS DISORDER 105 0.0157
117 SEROTONIN SYNDROME 300 0.0156
118 PERSONALITY CHANGE 144 0.0155
119 ARTERIOSPASM CORONARY 62 0.0154
120 EUPHORIC MOOD 155 0.0151
121 SEDATION COMPLICATION 38 0.0149
122 PERSONALITY DISORDER 39 0.0149
123 HALLUCINATION, VISUAL 311 0.0147
124 CLUMSINESS 40 0.0146
125 PRODUCT COLOUR ISSUE 75 0.0146
126 DEPRESSIVE SYMPTOM 51 0.0145
127 EMOTIONAL DISORDER 439 0.0142
128 CARDIAC VALVE DISEASE 81 0.0142
129 DELUSION 214 0.0138
130 PANIC REACTION 99 0.0137
131 DRUG USE DISORDER 115 0.0137
132 HYPERTONIC BLADDER 39 0.0135
133 FEELING DRUNK 98 0.0132
134 MOOD SWINGS 420 0.0132
135 SUICIDE ATTEMPT 798 0.0131
136 PETIT MAL EPILEPSY 67 0.0131
137 CRYING 476 0.0131
138 PERFORMANCE STATUS DECREASED 60 0.0128
139 HYPERPROLACTINAEMIA 83 0.0128
140 DYSKINESIA 516 0.0127
141 AUTONOMIC NERVOUS SYSTEM IMBALANCE 37 0.0127
142 POISONING 159 0.0126
143 PANIC DISORDER 49 0.0126
144 FEELING JITTERY 241 0.0126
145 COELIAC DISEASE 124 0.0126
146 DRUG ABUSE 1034 0.0124
147 HYPERREFLEXIA 43 0.0123
148 RESTLESSNESS 449 0.0123
149 HYPERVENTILATION 71 0.0122
150 INTRACRANIAL PRESSURE INCREASED 68 0.0122
151 HUNGER 167 0.0120
152 ANXIETY DISORDER 40 0.0120
153 ALCOHOL ABUSE 32 0.0120
154 THINKING ABNORMAL 220 0.0118
155 ARTERIOSCLEROSIS CORONARY ARTERY 77 0.0116
156 WITHDRAWAL SYNDROME 486 0.0116
157 STRABISMUS 34 0.0116
158 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 48 0.0115
159 HYPERACUSIS 43 0.0115
160 DECREASED INTEREST 68 0.0115
161 PANIC ATTACK 414 0.0113
162 FORMICATION 79 0.0113
163 MOOD ALTERED 309 0.0113
164 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 81 0.0113
165 GYNAECOMASTIA 348 0.0112
166 PSYCHIATRIC SYMPTOM 82 0.0111
167 ELECTROENCEPHALOGRAM ABNORMAL 35 0.0111
168 PRODUCT FORMULATION ISSUE 73 0.0111
169 OBESITY 175 0.0110
170 DRUG SCREEN POSITIVE 85 0.0107
171 CONCUSSION 83 0.0107
172 SCOLIOSIS 66 0.0106
173 AUTOIMMUNE THYROIDITIS 40 0.0106
174 DEPRESSED MOOD 559 0.0106
175 TACHYCARDIA 933 0.0105
176 SEDATION 275 0.0105
177 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 53 0.0103
178 INTENTIONAL OVERDOSE 661 0.0103
179 DYSPHEMIA 45 0.0103
180 APPETITE DISORDER 68 0.0102
181 THERAPEUTIC RESPONSE UNEXPECTED 460 0.0102
182 RESTLESS LEGS SYNDROME 186 0.0102
183 LYME DISEASE 34 0.0102
184 COMMUNICATION DISORDER 39 0.0102
185 PRESCRIBED OVERDOSE 196 0.0101
186 INCREASED APPETITE 193 0.0101
187 FRUSTRATION 36 0.0100
188 DEPRESSION 2276 0.0100
189 SEASONAL ALLERGY 140 0.0099
190 HALLUCINATION 737 0.0098
191 DRUG EFFECT LESS THAN EXPECTED 143 0.0096
192 VITAMIN B12 DEFICIENCY 39 0.0096
193 ANXIETY 2741 0.0096
194 MIDDLE INSOMNIA 179 0.0096
195 BLOOD PRESSURE DIASTOLIC INCREASED 44 0.0095
196 TEARFULNESS 41 0.0095
197 AKATHISIA 128 0.0094
198 MUSCLE TWITCHING 216 0.0094
199 SPINAL FUSION SURGERY 38 0.0094
200 TENSION 57 0.0094
201 BRADYPHRENIA 61 0.0093
202 ANOREXIA 119 0.0092
203 NYSTAGMUS 49 0.0092
204 PRODUCT TASTE ABNORMAL 125 0.0092
205 EYE MOVEMENT DISORDER 63 0.0092
206 SOMNOLENCE 1850 0.0092
207 SOCIAL PROBLEM 38 0.0092
208 BUNDLE BRANCH BLOCK RIGHT 42 0.0091
209 DRUG ABUSER 56 0.0091
210 HYPERSOMNIA 259 0.0090
211 STREPTOCOCCAL INFECTION 50 0.0090
212 POOR QUALITY SLEEP 193 0.0090
213 POOR QUALITY DRUG ADMINISTERED 58 0.0090
214 EATING DISORDER 190 0.0089
215 SHOULDER OPERATION 38 0.0089
216 FEELING OF DESPAIR 41 0.0088
217 CATATONIA 46 0.0088
218 POLYDIPSIA 34 0.0086
219 ENDOMETRIOSIS 41 0.0086
220 GALACTORRHOEA 55 0.0086
221 SURGERY 501 0.0085
222 DRUG EFFECT DECREASED 456 0.0085
223 GRAND MAL CONVULSION 78 0.0084
224 FRUSTRATION TOLERANCE DECREASED 68 0.0084
225 CONGESTIVE CARDIOMYOPATHY 35 0.0084
226 FOOD CRAVING 44 0.0084
227 SLEEP TERROR 35 0.0083
228 INCOHERENT 53 0.0082
229 BRAIN INJURY 82 0.0082
230 ERECTION INCREASED 34 0.0081
231 SUSPECTED SUICIDE 38 0.0081
232 SLEEP DISORDER 572 0.0081
233 DYSPHORIA 41 0.0081
234 IMPAIRED DRIVING ABILITY 92 0.0081
235 METABOLIC DISORDER 47 0.0081
236 PERIPHERAL COLDNESS 111 0.0081
237 NIGHTMARE 278 0.0080
238 MENTAL DISORDER 349 0.0080
239 ELECTROCARDIOGRAM QT PROLONGED 288 0.0080
240 VITAMIN D DEFICIENCY 78 0.0080
241 INSOMNIA 2127 0.0080
242 TREATMENT NONCOMPLIANCE 435 0.0079
243 GLUCOSE TOLERANCE IMPAIRED 47 0.0079
244 OVERWEIGHT 42 0.0078
245 COORDINATION ABNORMAL 109 0.0078
246 REBOUND EFFECT 88 0.0078
247 FOOD ALLERGY 60 0.0078
248 ENERGY INCREASED 45 0.0076
249 MENTAL IMPAIRMENT 184 0.0076
250 URINARY INCONTINENCE 224 0.0076
251 LIGAMENT SPRAIN 74 0.0075
252 HEART RATE INCREASED 740 0.0075
253 THERAPEUTIC PRODUCT EFFECT DELAYED 34 0.0074
254 ANAL INCONTINENCE 67 0.0074
255 FIBROMYALGIA 181 0.0074
256 RHINITIS ALLERGIC 33 0.0074
257 SINUS TACHYCARDIA 105 0.0074
258 BODY TEMPERATURE INCREASED 150 0.0073
259 NEUROLOGICAL SYMPTOM 42 0.0073
260 SCHIZOPHRENIA 89 0.0073
261 TYPE 1 DIABETES MELLITUS 44 0.0073
262 FEAR 196 0.0073
263 MALABSORPTION 38 0.0073
264 MULTIPLE DRUG OVERDOSE 36 0.0072
265 TOXICITY TO VARIOUS AGENTS 1213 0.0072
266 FEELING ABNORMAL 1721 0.0072
267 INTERVERTEBRAL DISC DEGENERATION 66 0.0071
268 FOOT FRACTURE 135 0.0071
269 TONSILLITIS 37 0.0071
270 PAPILLOEDEMA 32 0.0071
271 SEXUAL DYSFUNCTION 83 0.0071
272 PARTIAL SEIZURES 37 0.0071
273 DECREASED APPETITE 1628 0.0070
274 ATAXIA 83 0.0070
275 SLUGGISHNESS 71 0.0070
276 BRAIN FOG 109 0.0069
277 DRUG PRESCRIBING ERROR 133 0.0069
278 STATUS EPILEPTICUS 78 0.0069
279 INTENTIONAL DRUG MISUSE 144 0.0069
280 BLEPHAROSPASM 43 0.0068
281 MIGRAINE 651 0.0068
282 HYPOKINESIA 99 0.0068
283 THERAPEUTIC RESPONSE SHORTENED 226 0.0068
284 HYSTERECTOMY 59 0.0068
285 HYPERTHERMIA 52 0.0068
286 MYOCARDITIS 78 0.0068
287 SUPRAVENTRICULAR TACHYCARDIA 65 0.0068
288 PALPITATIONS 794 0.0068
289 INTENTIONAL PRODUCT USE ISSUE 592 0.0068
290 ELECTROCARDIOGRAM ABNORMAL 53 0.0067
291 FAILURE TO THRIVE 35 0.0067
292 STRESS CARDIOMYOPATHY 39 0.0067
293 PERONEAL NERVE PALSY 38 0.0067
294 PRODUCT RESIDUE PRESENT 36 0.0067
295 VITAMIN D DECREASED 57 0.0067
296 DROOLING 46 0.0067
297 BRAIN OEDEMA 84 0.0066
298 INABILITY TO AFFORD MEDICATION 66 0.0066
299 TARDIVE DYSKINESIA 187 0.0066
300 PROTEIN URINE PRESENT 33 0.0066
301 COMPLETED SUICIDE 551 0.0066
302 INSURANCE ISSUE 101 0.0066
303 APNOEA 51 0.0065
304 UNRESPONSIVE TO STIMULI 169 0.0065
305 MUSCLE TIGHTNESS 106 0.0065
306 THIRST 115 0.0064
307 NERVOUSNESS 335 0.0064
308 NEUROLEPTIC MALIGNANT SYNDROME 76 0.0064
309 INTERVERTEBRAL DISC PROTRUSION 140 0.0064
310 JAW DISORDER 35 0.0064
311 CHOLECYSTECTOMY 73 0.0064
312 CYANOSIS 100 0.0064
313 BACK INJURY 69 0.0063
314 SUDDEN DEATH 67 0.0063
315 LETHARGY 363 0.0063
316 RETCHING 134 0.0063
317 TREMOR 1041 0.0063
318 NOCTURIA 76 0.0063
319 COGNITIVE DISORDER 290 0.0062
320 UNEVALUABLE EVENT 467 0.0062
321 FOOD POISONING 33 0.0062
322 ACTIVITIES OF DAILY LIVING IMPAIRED 122 0.0062
323 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 38 0.0061
324 DRUG INTERACTION 969 0.0061
325 TACHYPNOEA 83 0.0061
326 INTENTIONAL PRODUCT MISUSE 534 0.0061
327 PRODUCT PHYSICAL ISSUE 122 0.0060
328 ABNORMAL LOSS OF WEIGHT 41 0.0060
329 CARDIAC MURMUR 52 0.0060
330 SALIVARY HYPERSECRETION 60 0.0060
331 ERECTILE DYSFUNCTION 153 0.0060
332 RESPIRATORY DEPRESSION 73 0.0059
333 HYPERTONIA 34 0.0059
334 MEMORY IMPAIRMENT 812 0.0059
335 MITRAL VALVE INCOMPETENCE 66 0.0058
336 ABNORMAL WEIGHT GAIN 72 0.0058
337 CHOLECYSTITIS CHRONIC 39 0.0058
338 DIPLOPIA 151 0.0058
339 EXTRAPYRAMIDAL DISORDER 144 0.0058
340 ROAD TRAFFIC ACCIDENT 242 0.0058
341 INCONTINENCE 61 0.0058
342 SPEECH DISORDER 302 0.0058
343 ABNORMAL DREAMS 159 0.0058
344 HYPERHIDROSIS 741 0.0057
345 DRUG LEVEL INCREASED 95 0.0057
346 DISABILITY 113 0.0057
347 WEIGHT DECREASED 1591 0.0057
348 POISONING DELIBERATE 54 0.0057
349 THERAPEUTIC PRODUCT EFFECT DECREASED 254 0.0057
350 HYPERTENSION 1201 0.0057
351 BLADDER DISORDER 56 0.0056
352 WEIGHT INCREASED 1262 0.0056
353 DRUG DISPENSING ERROR 86 0.0056
354 AMNESIA 366 0.0056
355 GENERALISED TONIC-CLONIC SEIZURE 93 0.0056
356 MICTURITION URGENCY 64 0.0056
357 IMPAIRED GASTRIC EMPTYING 76 0.0056
358 DRUG EFFECT INCOMPLETE 202 0.0056
359 INTENTIONAL DOSE OMISSION 158 0.0055
360 EPILEPSY 169 0.0055
361 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
362 MUSCLE RIGIDITY 66 0.0055
363 BLOOD PRESSURE INCREASED 843 0.0055
364 DEPRESSED LEVEL OF CONSCIOUSNESS 218 0.0055
365 CONVULSION 315 0.0055
366 MOTOR DYSFUNCTION 56 0.0055
367 BLOOD CREATINE PHOSPHOKINASE INCREASED 158 0.0055
368 EAR INFECTION 146 0.0055
369 PRODUCT SUPPLY ISSUE 39 0.0055
370 HYPOTHYROIDISM 174 0.0054
371 ARTHROPOD BITE 40 0.0054
372 DYSARTHRIA 203 0.0054
373 DISORIENTATION 213 0.0054
374 ACCIDENT 64 0.0054
375 IMPAIRED WORK ABILITY 114 0.0053
376 MENTAL STATUS CHANGES 148 0.0053
377 NEPHROLITHIASIS 244 0.0053
378 GASTROENTERITIS VIRAL 96 0.0053
379 MUSCLE STRAIN 46 0.0053
380 ARRHYTHMIA 251 0.0053
381 SENSORY DISTURBANCE 85 0.0053
382 RESPIRATORY RATE INCREASED 47 0.0053
383 THERAPY CHANGE 52 0.0053
384 KNEE OPERATION 52 0.0053
385 HEPATIC STEATOSIS 98 0.0053
386 EXOSTOSIS 48 0.0053
387 ECCHYMOSIS 36 0.0052
388 DENTAL CARIES 58 0.0052
389 DRY MOUTH 425 0.0052
390 MIOSIS 42 0.0052
391 MENSTRUAL DISORDER 43 0.0052
392 PALLOR 141 0.0052
393 BODY TEMPERATURE DECREASED 51 0.0052
394 ORAL HERPES 101 0.0052
395 ANKLE FRACTURE 80 0.0052
396 DYSGRAPHIA 34 0.0052
397 APPENDICITIS 48 0.0051
398 SPINAL OSTEOARTHRITIS 45 0.0051
399 WRONG TECHNIQUE IN DRUG USAGE PROCESS 186 0.0051
400 MYOCLONUS 61 0.0051
401 CONFUSIONAL STATE 822 0.0051
402 INFUSION SITE SWELLING 32 0.0051
403 HEAD DISCOMFORT 90 0.0051
404 PHARYNGITIS STREPTOCOCCAL 55 0.0051
405 THERAPEUTIC RESPONSE DECREASED 308 0.0051
406 MUSCLE SPASTICITY 62 0.0050
407 TEMPERATURE INTOLERANCE 52 0.0050
408 QUALITY OF LIFE DECREASED 66 0.0049
409 DRUG LEVEL DECREASED 50 0.0049
410 PRODUCT USE COMPLAINT 77 0.0049
411 SEIZURE 564 0.0049
412 NERVE COMPRESSION 45 0.0049
413 HYPERAESTHESIA 40 0.0049
414 CEREBRAL DISORDER 36 0.0049
415 LYMPHOCYTE COUNT DECREASED 86 0.0049
416 IRRITABLE BOWEL SYNDROME 104 0.0048
417 CONDITION AGGRAVATED 1470 0.0048
418 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 232 0.0048
419 DERMATITIS CONTACT 55 0.0048
420 PRODUCT DISPENSING ERROR 105 0.0048
421 LIQUID PRODUCT PHYSICAL ISSUE 35 0.0048
422 LOSS OF LIBIDO 43 0.0048
423 SINUSITIS 489 0.0048
424 BREAST MASS 32 0.0048
425 ROTATOR CUFF SYNDROME 61 0.0047
426 NIGHT SWEATS 153 0.0047
427 TROPONIN INCREASED 36 0.0047
428 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 32 0.0047
429 LOSS OF CONSCIOUSNESS 603 0.0047
430 HOSPITALISATION 718 0.0047
431 RIB FRACTURE 96 0.0047
432 HEAD INJURY 147 0.0046
433 SPINAL OPERATION 57 0.0046
434 VENTRICULAR EXTRASYSTOLES 48 0.0046
435 THERAPY PARTIAL RESPONDER 72 0.0046
436 CARDIO-RESPIRATORY ARREST 193 0.0046
437 APHASIA 139 0.0046
438 HEADACHE 2883 0.0046
439 DRUG INEFFECTIVE 6038 0.0046
440 TOOTH EXTRACTION 57 0.0046
441 HYPERTHYROIDISM 66 0.0046
442 ATELECTASIS 44 0.0045
443 NEURALGIA 110 0.0045
444 IMPAIRED QUALITY OF LIFE 65 0.0045
445 CARPAL TUNNEL SYNDROME 63 0.0045
446 TINNITUS 206 0.0045
447 ALTERED STATE OF CONSCIOUSNESS 97 0.0045
448 SENSORY LOSS 36 0.0045
449 HYPOPHAGIA 114 0.0045
450 LIMB INJURY 121 0.0045
451 HEAVY MENSTRUAL BLEEDING 40 0.0044
452 ACUTE MYOCARDIAL INFARCTION 131 0.0044
453 DRUG DOSE OMISSION 734 0.0044
454 DELIRIUM 154 0.0044
455 GASTROOESOPHAGEAL REFLUX DISEASE 356 0.0044
456 SENSATION OF FOREIGN BODY 37 0.0044
457 MULTIPLE SCLEROSIS RELAPSE 299 0.0044
458 PRODUCT QUALITY ISSUE 592 0.0044
459 BALANCE DISORDER 375 0.0043
460 MOVEMENT DISORDER 139 0.0043
461 SKIN LACERATION 47 0.0043
462 MUSCULOSKELETAL DISCOMFORT 74 0.0043
463 PHARYNGEAL SWELLING 42 0.0043
464 SINUS DISORDER 85 0.0043
465 THYROID DISORDER 66 0.0043
466 BLOOD CHOLESTEROL INCREASED 199 0.0043
467 BACK DISORDER 69 0.0042
468 SINUS BRADYCARDIA 41 0.0042
469 OVERDOSE 913 0.0042
470 KIDNEY INFECTION 83 0.0042
471 SINUS CONGESTION 57 0.0042
472 EXPOSURE DURING PREGNANCY 262 0.0042
473 VISION BLURRED 577 0.0042
474 PHOTOPHOBIA 79 0.0042
475 HYPOAESTHESIA 628 0.0042
476 POLLAKIURIA 174 0.0042
477 BLOOD PRESSURE FLUCTUATION 100 0.0042
478 OSTEOPENIA 63 0.0041
479 ADVERSE EVENT 382 0.0041
480 FACIAL PAIN 37 0.0041
481 PRODUCT ADHESION ISSUE 147 0.0041
482 CHEST PAIN 761 0.0041
483 BRONCHITIS 302 0.0041
484 TREATMENT FAILURE 338 0.0041
485 FATIGUE 3126 0.0040
486 SCIATICA 64 0.0040
487 PRODUCT ODOUR ABNORMAL 42 0.0040
488 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
489 PHARMACEUTICAL PRODUCT COMPLAINT 104 0.0040
490 CARDIOMYOPATHY 59 0.0040
491 HEART RATE DECREASED 140 0.0040
492 SCRATCH 42 0.0040
493 ANGINA PECTORIS 114 0.0040
494 DRUG TOXICITY 54 0.0040
495 GLAUCOMA 76 0.0039
496 VIRAL INFECTION 131 0.0039
497 AMENORRHOEA 69 0.0039
498 NECK PAIN 219 0.0039
499 PRODUCT USE ISSUE 736 0.0039
500 SCAR 67 0.0039
501 BLOOD THYROID STIMULATING HORMONE INCREASED 36 0.0039
502 POLYURIA 32 0.0039
503 SPINAL DISORDER 37 0.0039
504 HEART RATE IRREGULAR 88 0.0039
505 JOINT INJURY 83 0.0039
506 FEELING COLD 108 0.0039
507 PRODUCT DOSE OMISSION ISSUE 1140 0.0039
508 TOOTHACHE 70 0.0039
509 HYPOAESTHESIA ORAL 58 0.0038
510 HEMIPLEGIA 32 0.0038
511 BLOOD PRESSURE ABNORMAL 76 0.0038
512 BRAIN NEOPLASM 35 0.0038
513 HYPOTONIA 38 0.0038
514 DRUG DEPENDENCE 612 0.0038
515 BLOOD TRIGLYCERIDES INCREASED 67 0.0038
516 MUSCLE SPASMS 695 0.0038
517 CYST 47 0.0038
518 HIATUS HERNIA 49 0.0038
519 JOINT DISLOCATION 40 0.0038
520 COMA 180 0.0038
521 SYNCOPE 378 0.0038
522 APPLICATION SITE IRRITATION 47 0.0038
523 URINARY RETENTION 126 0.0038
524 PARAESTHESIA 594 0.0038
525 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
526 MEDICATION ERROR 208 0.0037
527 DRUG INTOLERANCE 361 0.0037
528 TOOTH ABSCESS 38 0.0037
529 MUSCULAR WEAKNESS 424 0.0037
530 WEIGHT FLUCTUATION 39 0.0037
531 TOOTH INFECTION 49 0.0037
532 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
533 PHARYNGITIS 46 0.0037
534 FEELING HOT 227 0.0037
535 EAR DISCOMFORT 38 0.0037
536 OVARIAN CYST 37 0.0037
537 APPLICATION SITE ERYTHEMA 97 0.0037
538 NAUSEA 2924 0.0037
539 TOOTH DISORDER 82 0.0037
540 NERVE INJURY 41 0.0037
541 IRON DEFICIENCY ANAEMIA 34 0.0037
542 ABDOMINAL PAIN UPPER 758 0.0037
543 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 260 0.0037
544 CIRCULATORY COLLAPSE 62 0.0036
545 ACCIDENTAL OVERDOSE 133 0.0036
546 COLD SWEAT 64 0.0036
547 ECONOMIC PROBLEM 55 0.0036
548 VOMITING 1704 0.0036
549 LACERATION 34 0.0036
550 DECREASED ACTIVITY 39 0.0036
551 PNEUMONIA ASPIRATION 90 0.0036
552 HYPERLIPIDAEMIA 43 0.0036
553 RHABDOMYOLYSIS 149 0.0036
554 NASOPHARYNGITIS 657 0.0036
555 HYPOTHERMIA 36 0.0036
556 DIZZINESS 1771 0.0035
557 GASTROINTESTINAL PAIN 39 0.0035
558 ORAL PAIN 79 0.0035
559 MULTIPLE SCLEROSIS 168 0.0035
560 STEVENS-JOHNSON SYNDROME 78 0.0035
561 HYPERTENSIVE CRISIS 39 0.0035
562 DRUG ADMINISTRATION ERROR 107 0.0035
563 RETINAL DETACHMENT 32 0.0035
564 DRUG WITHDRAWAL SYNDROME 304 0.0035
565 TYPE 2 DIABETES MELLITUS 116 0.0034
566 OSTEOARTHRITIS 146 0.0034
567 INTRAOCULAR PRESSURE INCREASED 44 0.0034
568 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
569 HAEMATOCRIT DECREASED 68 0.0034
570 FOETAL EXPOSURE DURING PREGNANCY 278 0.0034
571 ILLNESS 352 0.0034
572 FALL 1133 0.0034
573 DIZZINESS POSTURAL 33 0.0034
574 COLITIS ULCERATIVE 152 0.0034
575 ASTHMA 384 0.0034
576 LIMB DISCOMFORT 105 0.0034
577 DRY EYE 169 0.0034
578 AUTOIMMUNE DISORDER 33 0.0034
579 EYE DISORDER 111 0.0034
580 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 240 0.0034
581 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 682 0.0034
582 VERTIGO 205 0.0034
583 ADVERSE DRUG REACTION 302 0.0034
584 HEPATOMEGALY 33 0.0034
585 GAIT DISTURBANCE 639 0.0033
586 RESPIRATORY ARREST 92 0.0033
587 HAEMORRHOIDS 65 0.0033
588 THERAPY CESSATION 171 0.0033
589 FRACTURE 63 0.0033
590 NEUTROPHIL COUNT INCREASED 34 0.0033
591 OFF LABEL USE 2897 0.0033
592 GASTROINTESTINAL DISORDER 296 0.0033
593 OCULAR DISCOMFORT 37 0.0033
594 TENDONITIS 51 0.0033
595 PANCREATITIS ACUTE 74 0.0033
596 BLOOD PRESSURE SYSTOLIC INCREASED 64 0.0033
597 ANHEDONIA 86 0.0033
598 CARDIAC ARREST 270 0.0033
599 NASAL CONGESTION 191 0.0032
600 DISCOMFORT 198 0.0032
601 ADVERSE REACTION 43 0.0032
602 BONE DISORDER 59 0.0032
603 CHOKING 63 0.0032
604 BLOOD POTASSIUM DECREASED 97 0.0032
605 APHONIA 45 0.0032
606 BRADYCARDIA 171 0.0032
607 SKIN INFECTION 36 0.0032
608 RESPIRATORY DISORDER 96 0.0032
609 VISUAL ACUITY REDUCED 106 0.0032
610 EAR PAIN 62 0.0032
611 DIABETES MELLITUS 243 0.0032
612 PULMONARY CONGESTION 42 0.0032
613 MOUTH ULCERATION 67 0.0032
614 DYSPHAGIA 300 0.0032
615 FEEDING DISORDER 64 0.0032
616 ARTHRITIS 248 0.0031
617 GASTROENTERITIS 46 0.0031
618 VENTRICULAR FIBRILLATION 35 0.0031
619 DYSSTASIA 92 0.0031
620 ABDOMINAL DISCOMFORT 528 0.0031
621 PARALYSIS 45 0.0031
622 HYPERSENSITIVITY 580 0.0031
623 INFLUENZA 348 0.0031
624 PULMONARY HYPERTENSION 65 0.0031
625 PHARYNGEAL OEDEMA 48 0.0031
626 BLOOD IRON DECREASED 37 0.0031
627 INFUSION SITE PAIN 40 0.0031
628 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170 0.0031
629 POOR VENOUS ACCESS 32 0.0031
630 PRESYNCOPE 75 0.0031
631 TOOTH FRACTURE 34 0.0031
632 DYSURIA 113 0.0031
633 FOOT DEFORMITY 34 0.0031
634 PETECHIAE 32 0.0031
635 RHINORRHOEA 198 0.0031
636 GAIT INABILITY 102 0.0030
637 CHOLELITHIASIS 100 0.0030
638 MALNUTRITION 34 0.0030
639 ASPIRATION 33 0.0030
640 UPPER LIMB FRACTURE 60 0.0030
641 DYSPEPSIA 296 0.0030
642 OROPHARYNGEAL PAIN 278 0.0030
643 BACTERIAL INFECTION 56 0.0030
644 PAIN IN JAW 85 0.0030
645 LYMPHADENOPATHY 106 0.0030
646 UPPER RESPIRATORY TRACT INFECTION 138 0.0030
647 CONTUSION 287 0.0030
648 LYMPHOPENIA 42 0.0030
649 ACNE 225 0.0030
650 VENTRICULAR TACHYCARDIA 49 0.0030
651 PHOTOSENSITIVITY REACTION 49 0.0030
652 SWOLLEN TONGUE 92 0.0029
653 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
654 BRONCHOSPASM 42 0.0029
655 DYSMENORRHOEA 39 0.0029
656 ABDOMINAL PAIN 684 0.0029
657 PRODUCT PRESCRIBING ERROR 70 0.0029
658 WOUND 82 0.0029
659 WRIST FRACTURE 35 0.0029
660 INJURY 205 0.0029
661 GALLBLADDER DISORDER 52 0.0029
662 PRODUCT DOSE OMISSION 190 0.0029
663 MENORRHAGIA 57 0.0029
664 SPINAL PAIN 34 0.0029
665 PNEUMOTHORAX 46 0.0029
666 MALAISE 1272 0.0029
667 ALANINE AMINOTRANSFERASE INCREASED 178 0.0029
668 HYPOXIA 102 0.0029
669 CONSTIPATION 631 0.0029
670 FLUSHING 294 0.0029
671 THERAPY NON-RESPONDER 130 0.0029
672 VISUAL IMPAIRMENT 358 0.0029
673 INCORRECT ROUTE OF DRUG ADMINISTRATION 103 0.0029
674 CELLULITIS 145 0.0029
675 CARDIOVASCULAR DISORDER 73 0.0029
676 ORTHOSTATIC HYPOTENSION 50 0.0029
677 LOWER LIMB FRACTURE 55 0.0029
678 CHEST DISCOMFORT 293 0.0029
679 EPISTAXIS 214 0.0029
680 BLOOD ALKALINE PHOSPHATASE INCREASED 71 0.0029
681 NERVOUS SYSTEM DISORDER 89 0.0028
682 KNEE ARTHROPLASTY 60 0.0028
683 CARDIOMEGALY 35 0.0028
684 BLOOD PRESSURE DECREASED 189 0.0028
685 MUSCULOSKELETAL CHEST PAIN 44 0.0028
686 SKIN HAEMORRHAGE 42 0.0028
687 HEMIPARESIS 48 0.0028
688 DEAFNESS 74 0.0028
689 PRODUCT PREPARATION ERROR 58 0.0028
690 ABSCESS 45 0.0028
691 SKIN DISORDER 94 0.0028
692 ASTHENIA 1058 0.0028
693 THROAT TIGHTNESS 76 0.0028
694 ANKYLOSING SPONDYLITIS 37 0.0028
695 SCAB 32 0.0028
696 RESPIRATORY TRACT INFECTION 73 0.0028
697 PREGNANCY 56 0.0028
698 SECRETION DISCHARGE 35 0.0028
699 DEHYDRATION 372 0.0028
700 CEREBRAL INFARCTION 68 0.0028
701 GASTRITIS 73 0.0028
702 MUSCLE ATROPHY 35 0.0028
703 ASPARTATE AMINOTRANSFERASE INCREASED 146 0.0027
704 URINARY TRACT INFECTION 468 0.0027
705 BEDRIDDEN 36 0.0027
706 BACK PAIN 636 0.0027
707 SKIN LESION 75 0.0027
708 UVEITIS 37 0.0027
709 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
710 HEPATIC ENZYME INCREASED 185 0.0027
711 FLUID RETENTION 138 0.0027
712 CONTRAINDICATED PRODUCT ADMINISTERED 82 0.0027
713 LIP SWELLING 90 0.0027
714 SKIN DISCOLOURATION 124 0.0027
715 SWELLING FACE 175 0.0027
716 PLATELET COUNT INCREASED 35 0.0027
717 HAEMATOCHEZIA 148 0.0027
718 PRODUCT ADMINISTRATION ERROR 54 0.0027
719 ABASIA 66 0.0027
720 DYSPHONIA 156 0.0027
721 DEVICE RELATED INFECTION 41 0.0027
722 MUSCULOSKELETAL STIFFNESS 233 0.0027
723 MENSTRUATION IRREGULAR 71 0.0026
724 SARS-COV-2 TEST POSITIVE 35 0.0026
725 DEEP VEIN THROMBOSIS 171 0.0026
726 SKIN REACTION 37 0.0026
727 CATARACT 155 0.0026
728 HAEMATURIA 89 0.0026
729 ABORTION SPONTANEOUS 104 0.0026
730 FREQUENT BOWEL MOVEMENTS 70 0.0026
731 ORAL CANDIDIASIS 34 0.0026
732 BLOOD URINE PRESENT 49 0.0026
733 CYSTITIS 82 0.0026
734 PULMONARY EMBOLISM 244 0.0026
735 GASTRIC DISORDER 87 0.0025
736 DRUG EXPOSURE DURING PREGNANCY 86 0.0025
737 GASTRIC ULCER 48 0.0025
738 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 453 0.0025
739 HEPATIC CYTOLYSIS 32 0.0025
740 RESPIRATORY DISTRESS 69 0.0025
741 POST PROCEDURAL COMPLICATION 48 0.0025
742 PAIN IN EXTREMITY 736 0.0025
743 STAPHYLOCOCCAL INFECTION 82 0.0025
744 EYE PAIN 140 0.0025
745 NEUROPATHY PERIPHERAL 236 0.0025
746 EMOTIONAL DISTRESS 299 0.0025
747 WHEEZING 146 0.0025
748 COUGH 690 0.0025
749 GLOSSODYNIA 55 0.0025
750 OSTEOPOROSIS 101 0.0025
751 THROAT IRRITATION 110 0.0024
752 HYPOKALAEMIA 113 0.0024
753 MUSCULOSKELETAL PAIN 128 0.0024
754 DERMATITIS 51 0.0024
755 LEUKOCYTOSIS 44 0.0024
756 INCORRECT DOSE ADMINISTERED 555 0.0024
757 IMMUNE SYSTEM DISORDER 32 0.0024
758 CANDIDA INFECTION 41 0.0024
759 MUSCULOSKELETAL DISORDER 46 0.0024
760 HYPERGLYCAEMIA 88 0.0024
761 PRODUCTIVE COUGH 115 0.0024
762 PRODUCT USE IN UNAPPROVED INDICATION 597 0.0024
763 LIVER FUNCTION TEST ABNORMAL 70 0.0024
764 CLOSTRIDIUM DIFFICILE INFECTION 52 0.0024
765 RED BLOOD CELL COUNT DECREASED 68 0.0024
766 PAIN 1461 0.0024
767 OSTEOMYELITIS 43 0.0024
768 DYSGEUSIA 176 0.0024
769 JOINT STIFFNESS 62 0.0024
770 INFLUENZA LIKE ILLNESS 194 0.0024
771 COVID-19 413 0.0024
772 ALOPECIA 462 0.0024
773 IMMUNODEFICIENCY 35 0.0023
774 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
775 BLOOD BILIRUBIN INCREASED 63 0.0023
776 URTICARIA 390 0.0023
777 ABDOMINAL DISTENSION 243 0.0023
778 HERNIA 45 0.0023
779 LIVER INJURY 57 0.0023
780 HOT FLUSH 175 0.0023
781 SNEEZING 52 0.0023
782 PYREXIA 802 0.0023
783 TOOTH LOSS 48 0.0023
784 ECZEMA 121 0.0023
785 DYSPNOEA EXERTIONAL 87 0.0023
786 PULMONARY OEDEMA 103 0.0023
787 TRANSIENT ISCHAEMIC ATTACK 77 0.0023
788 RESPIRATORY TRACT CONGESTION 36 0.0023
789 ANAPHYLACTIC REACTION 124 0.0022
790 EYE SWELLING 83 0.0022
791 COLITIS 84 0.0022
792 OEDEMA 120 0.0022
793 STOMATITIS 134 0.0022
794 CHILLS 257 0.0022
795 FUNGAL INFECTION 73 0.0022
796 METABOLIC ACIDOSIS 70 0.0022
797 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 37 0.0022
798 MYALGIA 365 0.0021
799 METASTASES TO BONE 35 0.0021
800 DERMATITIS ATOPIC 112 0.0021
801 ARTHROPATHY 118 0.0021
802 LACRIMATION INCREASED 64 0.0021
803 TRANSAMINASES INCREASED 47 0.0021
804 HYPOTENSION 422 0.0021
805 CONJUNCTIVITIS 39 0.0021
806 DEVICE BREAKAGE 85 0.0021
807 HAEMATEMESIS 53 0.0021
808 ACUTE RESPIRATORY FAILURE 40 0.0021
809 DYSPNOEA 1176 0.0021
810 ARTHRALGIA 863 0.0021
811 RASH 904 0.0021
812 NO ADVERSE EVENT 375 0.0021
813 ERUCTATION 40 0.0021
814 PNEUMONIA 668 0.0021
815 SWELLING 193 0.0021
816 GOUT 37 0.0021
817 OEDEMA PERIPHERAL 251 0.0021
818 SKIN FISSURES 40 0.0020
819 JAUNDICE 55 0.0020
820 DRUG-INDUCED LIVER INJURY 64 0.0020
821 CHROMATURIA 46 0.0020
822 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
823 PRURITUS GENERALISED 44 0.0020
824 PANCREATITIS 107 0.0020
825 EXTRA DOSE ADMINISTERED 82 0.0020
826 PRODUCT PRESCRIBING ISSUE 44 0.0020
827 PRESCRIBED UNDERDOSE 40 0.0020
828 VAGINAL HAEMORRHAGE 87 0.0020
829 ANGIOEDEMA 87 0.0020
830 OCULAR HYPERAEMIA 93 0.0020
831 FACE OEDEMA 33 0.0020
832 HERPES ZOSTER 112 0.0019
833 PRURITUS 745 0.0019
834 HYPOGLYCAEMIA 94 0.0019
835 RASH GENERALISED 50 0.0019
836 HIP FRACTURE 62 0.0019
837 CEREBRAL HAEMORRHAGE 69 0.0019
838 BURNING SENSATION 135 0.0019
839 DIARRHOEA 1242 0.0019
840 MOBILITY DECREASED 138 0.0019
841 FAECES DISCOLOURED 41 0.0019
842 BLINDNESS 77 0.0019
843 FLATULENCE 107 0.0019
844 INFLAMMATION 97 0.0019
845 ENCEPHALOPATHY 46 0.0019
846 TASTE DISORDER 38 0.0019
847 PELVIC PAIN 34 0.0019
848 DISEASE RECURRENCE 89 0.0019
849 TUBULOINTERSTITIAL NEPHRITIS 35 0.0019
850 LEUKOPENIA 93 0.0019
851 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 34 0.0019
852 INCORRECT DRUG ADMINISTRATION DURATION 52 0.0018
853 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
854 INFUSION RELATED REACTION 122 0.0018
855 DIVERTICULITIS 51 0.0018
856 DRUG RESISTANCE 47 0.0018
857 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 95 0.0018
858 INFECTION 263 0.0018
859 RECTAL HAEMORRHAGE 78 0.0018
860 EXPIRED PRODUCT ADMINISTERED 60 0.0018
861 BLOOD SODIUM DECREASED 34 0.0018
862 RASH ERYTHEMATOUS 86 0.0018
863 IMPAIRED HEALING 59 0.0018
864 ISCHAEMIC STROKE 32 0.0018
865 ATRIAL FIBRILLATION 174 0.0018
866 PERIPHERAL SWELLING 274 0.0018
867 CARDIAC DISORDER 166 0.0018
868 PNEUMONITIS 48 0.0018
869 SPINAL FRACTURE 35 0.0017
870 HYPOACUSIS 75 0.0017
871 CHRONIC KIDNEY DISEASE 132 0.0017
872 PROCEDURAL PAIN 48 0.0017
873 PSORIATIC ARTHROPATHY 70 0.0017
874 INTESTINAL OBSTRUCTION 65 0.0017
875 HEPATITIS 44 0.0017
876 ERYTHEMA 352 0.0017
877 ABDOMINAL PAIN LOWER 43 0.0017
878 ILL-DEFINED DISORDER 103 0.0017
879 BLISTER 95 0.0017
880 AGEUSIA 42 0.0017
881 APPLICATION SITE PAIN 37 0.0017
882 THROMBOSIS 135 0.0017
883 APPLICATION SITE PRURITUS 38 0.0017
884 CHOLESTASIS 32 0.0017
885 DRY SKIN 222 0.0017
886 DEMENTIA 46 0.0016
887 MATERNAL EXPOSURE DURING PREGNANCY 146 0.0016
888 PAIN OF SKIN 44 0.0016
889 RASH MACULAR 57 0.0016
890 LABORATORY TEST ABNORMAL 48 0.0016
891 SKIN ULCER 42 0.0016
892 DIABETIC KETOACIDOSIS 39 0.0016
893 HAEMATOMA 42 0.0016
894 HAEMOPTYSIS 45 0.0016
895 OXYGEN SATURATION DECREASED 90 0.0016
896 SKIN EXFOLIATION 135 0.0016
897 CEREBROVASCULAR ACCIDENT 271 0.0016
898 HYPONATRAEMIA 90 0.0016
899 THERAPY INTERRUPTED 114 0.0016
900 PLEURAL EFFUSION 97 0.0016
901 WHITE BLOOD CELL COUNT DECREASED 172 0.0016
902 EYE PRURITUS 53 0.0016
903 UNDERDOSE 115 0.0016
904 LOCALISED INFECTION 38 0.0016
905 MYOCARDIAL INFARCTION 272 0.0016
906 SKIN IRRITATION 71 0.0015
907 RENAL DISORDER 72 0.0015
908 ANAEMIA 292 0.0015
909 BLOOD GLUCOSE DECREASED 73 0.0015
910 BONE PAIN 89 0.0015
911 DEVICE ISSUE 135 0.0015
912 PRODUCT COMPLAINT 38 0.0015
913 RASH PRURITIC 81 0.0015
914 CORONARY ARTERY DISEASE 45 0.0015
915 PERICARDIAL EFFUSION 34 0.0015
916 RESPIRATORY FAILURE 106 0.0015
917 RENAL FAILURE ACUTE 61 0.0014
918 PREMATURE BABY 43 0.0014
919 INJECTION SITE URTICARIA 35 0.0014
920 SEPSIS 159 0.0014
921 HAEMOGLOBIN DECREASED 146 0.0014
922 EYE IRRITATION 81 0.0014
923 HAEMORRHAGE 143 0.0014
924 LUNG DISORDER 67 0.0014
925 GENERAL PHYSICAL HEALTH DETERIORATION 155 0.0013
926 OSTEONECROSIS OF JAW 33 0.0013
927 RHEUMATOID ARTHRITIS 151 0.0013
928 SYSTEMIC LUPUS ERYTHEMATOSUS 47 0.0013
929 C-REACTIVE PROTEIN INCREASED 48 0.0013
930 JOINT SWELLING 159 0.0013
931 GLYCOSYLATED HAEMOGLOBIN INCREASED 33 0.0013
932 BLOOD CREATININE INCREASED 85 0.0013
933 RENAL FAILURE 172 0.0013
934 FEMUR FRACTURE 40 0.0013
935 NEEDLE ISSUE 37 0.0013
936 HEPATIC FAILURE 38 0.0013
937 HEPATIC FUNCTION ABNORMAL 47 0.0013
938 NEUTROPHIL COUNT DECREASED 51 0.0013
939 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
940 LIVER DISORDER 55 0.0012
941 DRUG DOSE OMISSION BY DEVICE 96 0.0012
942 INJECTION SITE PRURITUS 82 0.0012
943 THROMBOCYTOPENIA 136 0.0012
944 MALIGNANT NEOPLASM PROGRESSION 124 0.0012
945 PLATELET COUNT DECREASED 129 0.0012
946 INJECTION SITE REACTION 83 0.0012
947 FEBRILE NEUTROPENIA 80 0.0012
948 NEUTROPENIA 161 0.0012
949 RENAL INJURY 35 0.0012
950 NEOPLASM PROGRESSION 40 0.0011
951 ACUTE KIDNEY INJURY 176 0.0011
952 PANCYTOPENIA 64 0.0011
953 LACTIC ACIDOSIS 37 0.0011
954 INJECTION SITE BRUISING 90 0.0011
955 DEVICE USE ERROR 39 0.0011
956 DEPENDENCE 61 0.0011
957 DEVICE LEAKAGE 48 0.0011
958 CARDIAC FAILURE 88 0.0011
959 OSTEONECROSIS 36 0.0011
960 DISEASE PROGRESSION 128 0.0011
961 RENAL IMPAIRMENT 90 0.0011
962 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36 0.0011
963 LOWER RESPIRATORY TRACT INFECTION 48 0.0011
964 INJECTION SITE MASS 39 0.0011
965 BLOOD GLUCOSE INCREASED 195 0.0010
966 SEPTIC SHOCK 45 0.0010
967 BONE DENSITY DECREASED 32 0.0010
968 INJECTION SITE PAIN 303 0.0010
969 ACCIDENTAL EXPOSURE TO PRODUCT 101 0.0010
970 SKIN BURNING SENSATION 68 0.0009
971 PSORIASIS 122 0.0009
972 CARDIAC FAILURE CONGESTIVE 73 0.0009
973 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 42 0.0009
974 INJECTION SITE SWELLING 68 0.0009
975 PRODUCT STORAGE ERROR 75 0.0009
976 INJECTION SITE ERYTHEMA 105 0.0008
977 DEVICE DISLOCATION 36 0.0008
978 PLASMA CELL MYELOMA 32 0.0008
979 DEVICE MALFUNCTION 49 0.0007
980 DEATH 596 0.0007
981 NEOPLASM MALIGNANT 44 0.0007
982 GASTROINTESTINAL HAEMORRHAGE 54 0.0006
983 DEVICE DIFFICULT TO USE 42 0.0006
984 DEVICE EXPULSION 41 0.0006
985 INJECTION SITE HAEMORRHAGE 49 0.0006
986 BREAST CANCER 54 0.0006